Cordis Corporation and ClearStream Technologies Group, plc Sign Distribution Agreement for Peripheral Angioplasty Balloon Catheters

WARREN, N.J., April 18 /PRNewswire/ -- Cordis Corporation and ClearStream Technologies Group, plc, announced today the signing of a definitive distribution agreement whereby Cordis will market ClearStream's most advanced percutaneous transluminal angioplasty (PTA) balloon catheters under the brand names SLEEK(TM) and SAVVY(R) LONG PTA Balloon Dilation Catheters. The SLEEK(TM) and SAVVY(R) LONG peripheral balloons will be marketed by the Cordis Endovascular division of Cordis Corporation. The companies expect the products will be commercially available in countries outside the United States starting in the second quarter of 2007.

"With SLEEK(TM) and the expansion of our existing SAVVY(R) product line with SAVVY(R) LONG, we are delivering on our commitment to increase the depth and breadth of our peripheral portfolio for physicians and the millions of patients with peripheral vascular disease they treat," said Dennis Donohoe, M.D., Vice President, Worldwide Clinical and Medical Affairs, Cordis Corporation.

The SLEEK(TM) and SAVVY(R) LONG Balloons will feature lengths up to 120 mm for treating long diffuse disease, and a lubricious coating for increased crossability in tight lesions. The SLEEK(TM) Balloon will be the first and only .014" guidewire compatible rapid-exchange (RX) balloon fully dedicated to infrapopliteal vessels, while the SAVVY(R) LONG Balloon will provide an .018" guidewire compatible over-the-wire (OTW) alternative for both superficial femoral and infrapopliteal arteries.

"We are pleased to announce this distribution agreement with Cordis Corporation to provide interventionalists with the tools they need every day in the treatment of the millions of patients around the world with peripheral vascular disease," said Andrew Jones, chief executive officer, ClearStream Technologies Group, plc.

Cordis Endovascular

Cordis Endovascular is a recognized leader in endovascular research and development and is committed to serving the cardiology, radiology and vascular surgery communities through the development of groundbreaking technologies for the treatment of peripheral vascular disease. It constantly seeks solutions to the human anatomy's most challenging problems, such as carotid artery disease, superficial femoral artery disease, venous thrombotic disease, lower extremity disease and aortic aneurysm.

About Cordis Corporation

Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in developing and manufacturing interventional vascular technology. Through the company's innovation, research and development, physicians worldwide are better able to treat the millions of patients who suffer from vascular disease.

About ClearStream Technologies Group, plc

ClearStream Technologies Group plc, based in Enniscorthy, Co Wexford, Ireland, is an innovative maker of medical devices used in interventional procedures, including catheters and stents. Its products are sold under ClearStream's own brands and are also supplied to Original Equipment Manufacturers. The company is listed on the AIM market of the London Stock Exchange.

CONTACT: Carol Goodrich of Cordis Corporation, +1-908-412-7332, or cell,+1-973-615-4057

Web site: http://www.cordis.com/